Amdocs Stock Probability Of Bankruptcy

DOX Stock

USD 84.17 0.01 0.01%

Amdocs' odds of distress is under 8% at this time. It has tiny probability of undergoing some form of financial hardship in the near future. Probability of bankruptcy shows the probability of financial torment over the next two years of operations under current economic and market conditions. All items used in analyzing the odds of distress are taken from the Amdocs balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Amdocs Piotroski F Score and Amdocs Altman Z Score analysis.

For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.

Market Cap is likely to drop to about 6.9 B in 2025. Enterprise Value is likely to drop to about 6.6 B in 2025

Amdocs Company probability of bankruptcy Analysis

Amdocs' Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Amdocs Probability Of Bankruptcy

Less than 8%

Most of Amdocs' fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amdocs is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Our calculation of Amdocs probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Amdocs odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Amdocs financial health.

Is IT Consulting & Other Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.11)

Dividend Share

1.872

Earnings Share

4.25

Revenue Per Share

43.337

Quarterly Revenue Growth

0.017

The market value of Amdocs is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amdocs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Amdocs Probability Of Bankruptcy Driver Correlations

Understanding the fundamental principles of building solid financial models for Amdocs is extremely important. It helps to project a fair market value of Amdocs Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since Amdocs' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Amdocs' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Amdocs' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Current Deferred Revenue	Long Term Debt	Good Will	Intangible Assets	Property Plant Equipment	Short Term Investments	Treasury Stock	Net Tangible Assets	Deferred Long Term Liab	Short Long Term Debt	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.95	0.26	0.77	0.03	0.93	0.94	0.76	0.01	0.94	0.34	0.55	0.91	-0.83	0.59	-0.21	-0.87	-0.61	-0.59	-0.59	0.59	0.53	-0.39	0.34
Total Stockholder Equity	0.95		-0.02	0.65	0.27	0.91	0.78	0.87	0.22	0.89	0.27	0.44	0.78	-0.9	0.35	-0.13	-0.82	-0.46	-0.48	-0.46	0.42	0.28	-0.27	0.18
Net Debt	0.26	-0.02		0.68	-0.68	0.24	0.53	-0.28	-0.54	0.35	0.15	0.66	0.51	0.03	0.89	-0.33	-0.4	-0.71	-0.65	-0.63	0.79	0.86	-0.62	0.67
Retained Earnings	0.77	0.65	0.68		-0.21	0.74	0.82	0.42	-0.17	0.85	0.29	0.79	0.82	-0.66	0.89	-0.25	-0.84	-0.8	-0.8	-0.7	0.85	0.77	-0.69	0.69
Accounts Payable	0.03	0.27	-0.68	-0.21		0.09	-0.23	0.42	0.14	0.05	-0.13	-0.21	-0.17	-0.3	-0.53	0.43	0.09	0.35	0.21	0.34	-0.41	-0.59	0.21	-0.27
Net Receivables	0.93	0.91	0.24	0.74	0.09		0.85	0.6	0.15	0.94	0.12	0.64	0.94	-0.77	0.49	-0.37	-0.88	-0.68	-0.69	-0.7	0.67	0.4	-0.58	0.34
Total Liab	0.94	0.78	0.53	0.82	-0.23	0.85		0.56	-0.22	0.89	0.38	0.59	0.94	-0.65	0.77	-0.25	-0.83	-0.69	-0.64	-0.66	0.71	0.74	-0.48	0.46
Total Current Assets	0.76	0.87	-0.28	0.42	0.42	0.6	0.56		0.18	0.66	0.4	0.06	0.44	-0.87	0.16	0.22	-0.52	-0.07	-0.08	-0.03	0.05	0.12	0.09	0.05
Short Term Debt	0.01	0.22	-0.54	-0.17	0.14	0.15	-0.22	0.18		0.02	-0.28	-0.05	-0.06	-0.21	-0.46	-0.22	-0.1	0.13	0.04	0.02	-0.17	-0.47	0.13	-0.33
Common Stock	0.94	0.89	0.35	0.85	0.05	0.94	0.89	0.66	0.02		0.21	0.63	0.92	-0.79	0.64	-0.24	-0.83	-0.66	-0.68	-0.62	0.75	0.6	-0.57	0.59
Current Deferred Revenue	0.34	0.27	0.15	0.29	-0.13	0.12	0.38	0.4	-0.28	0.21		0.09	0.18	-0.28	0.39	0.39	-0.29	-0.14	-0.08	0.01	0.05	0.26	0.21	0.02
Long Term Debt	0.55	0.44	0.66	0.79	-0.21	0.64	0.59	0.06	-0.05	0.63	0.09		0.74	-0.32	0.67	-0.42	-0.8	-0.9	-1.0	-0.86	0.84	0.58	-0.61	0.46
Good Will	0.91	0.78	0.51	0.82	-0.17	0.94	0.94	0.44	-0.06	0.92	0.18	0.74		-0.6	0.69	-0.41	-0.89	-0.81	-0.79	-0.8	0.81	0.64	-0.64	0.48
Intangible Assets	-0.83	-0.9	0.03	-0.66	-0.3	-0.77	-0.65	-0.87	-0.21	-0.79	-0.28	-0.32	-0.6		-0.38	-0.02	0.68	0.31	0.34	0.3	-0.33	-0.24	0.28	-0.25
Property Plant Equipment	0.59	0.35	0.89	0.89	-0.53	0.49	0.77	0.16	-0.46	0.64	0.39	0.67	0.69	-0.38		-0.21	-0.63	-0.73	-0.67	-0.62	0.82	0.92	-0.6	0.72
Short Term Investments	-0.21	-0.13	-0.33	-0.25	0.43	-0.37	-0.25	0.22	-0.22	-0.24	0.39	-0.42	-0.41	-0.02	-0.21		0.4	0.65	0.45	0.58	-0.52	-0.26	0.51	-0.13
Treasury Stock	-0.87	-0.82	-0.4	-0.84	0.09	-0.88	-0.83	-0.52	-0.1	-0.83	-0.29	-0.8	-0.89	0.68	-0.63	0.4		0.85	0.83	0.8	-0.7	-0.49	0.52	-0.26
Net Tangible Assets	-0.61	-0.46	-0.71	-0.8	0.35	-0.68	-0.69	-0.07	0.13	-0.66	-0.14	-0.9	-0.81	0.31	-0.73	0.65	0.85		0.91	0.87	-0.87	-0.64	0.71	-0.45
Deferred Long Term Liab	-0.59	-0.48	-0.65	-0.8	0.21	-0.69	-0.64	-0.08	0.04	-0.68	-0.08	-1.0	-0.79	0.34	-0.67	0.45	0.83	0.91		0.89	-0.86	-0.59	0.63	-0.47
Short Long Term Debt	-0.59	-0.46	-0.63	-0.7	0.34	-0.7	-0.66	-0.03	0.02	-0.62	0.01	-0.86	-0.8	0.3	-0.62	0.58	0.8	0.87	0.89		-0.84	-0.57	0.64	-0.35
Capital Surpluse	0.59	0.42	0.79	0.85	-0.41	0.67	0.71	0.05	-0.17	0.75	0.05	0.84	0.81	-0.33	0.82	-0.52	-0.7	-0.87	-0.86	-0.84		0.81	-0.78	0.78
Net Invested Capital	0.53	0.28	0.86	0.77	-0.59	0.4	0.74	0.12	-0.47	0.6	0.26	0.58	0.64	-0.24	0.92	-0.26	-0.49	-0.64	-0.59	-0.57	0.81		-0.46	0.77
Net Working Capital	-0.39	-0.27	-0.62	-0.69	0.21	-0.58	-0.48	0.09	0.13	-0.57	0.21	-0.61	-0.64	0.28	-0.6	0.51	0.52	0.71	0.63	0.64	-0.78	-0.46		-0.64
Capital Stock	0.34	0.18	0.67	0.69	-0.27	0.34	0.46	0.05	-0.33	0.59	0.02	0.46	0.48	-0.25	0.72	-0.13	-0.26	-0.45	-0.47	-0.35	0.78	0.77	-0.64

Click cells to compare fundamentals

The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.

Competition

Predict Amdocs

Based on the latest financial disclosure, Amdocs has a Probability Of Bankruptcy of 8.0%. This is 80.23% lower than that of the IT Services sector and significantly higher than that of the Information Technology industry. The probability of bankruptcy for all United States stocks is 79.91% higher than that of the company.

Amdocs Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amdocs' direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amdocs could also be used in its relative valuation, which is a method of valuing Amdocs by comparing valuation metrics of similar companies.

Amdocs is currently under evaluation in probability of bankruptcy category among its peers.

Amdocs Main Bankruptcy Drivers

	2020	2021	2022	2023	2024	2025 (projected)
Return On Assets	0.11	0.086	0.0841	0.0772	0.0695	0.0626
Net Debt	172.1M	253.5M	287.2M	443.7M	510.2M	535.7M
Total Current Liabilities	1.3B	1.3B	1.4B	1.5B	1.7B	1.0B
Non Current Liabilities Total	1.6B	1.6B	1.5B	1.4B	1.6B	1.7B
Total Assets	6.5B	6.4B	6.4B	6.4B	7.3B	4.6B
Total Current Assets	2.1B	2.0B	1.9B	1.8B	2.0B	1.9B
Total Cash From Operating Activities	925.8M	756.7M	822.6M	724.4M	833.1M	569.3M

Amdocs ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Amdocs' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Amdocs' managers, analysts, and investors.

Environmental

Governance

Social

Amdocs Fundamentals

	Return On Equity	0.14
	Return On Asset	0.0738
	Profit Margin	0.1 %
	Operating Margin	0.15 %
	Current Valuation	9.77 B
	Shares Outstanding	112.82 M
	Shares Owned By Institutions	99.57 %
	Number Of Shares Shorted	3.18 M
	Price To Earning	19.03 X
	Price To Book	2.75 X
	Price To Sales	1.90 X
	Revenue	5 B
	Gross Profit	1.62 B
	EBITDA	819.03 M
	Net Income	496.32 M
	Cash And Equivalents	817.98 M
	Cash Per Share	6.74 X
	Total Debt	789.74 M
	Debt To Equity	0.23 %
	Current Ratio	1.60 X
	Book Value Per Share	30.39 X
	Cash Flow From Operations	724.43 M
	Short Ratio	4.04 X
	Earnings Per Share	4.25 X
	Price To Earnings To Growth	1.10 X
	Target Price	102.12
	Beta	0.75
	Market Capitalization	9.5 B
	Total Asset	6.39 B
	Retained Earnings	6.83 B
	Working Capital	300.27 M
	Current Asset	2.1 B
	Current Liabilities	1.37 B
	Annual Yield	0.02 %
	Five Year Return	1.73 %
	Net Asset	6.39 B
	Last Dividend Paid	1.87

About Amdocs Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Amdocs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amdocs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amdocs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin

Additional Tools for Amdocs Stock Analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Amdocs Stock Probability Of Bankruptcy

Amdocs Company probability of bankruptcy Analysis

Probability Of Bankruptcy

Normalized

Z-Score

Current Amdocs Probability Of Bankruptcy

Amdocs Probability Of Bankruptcy Driver Correlations

Amdocs Probability Of Bankruptcy Peer Comparison

Amdocs Main Bankruptcy Drivers

Amdocs ESG Sustainability

Amdocs Fundamentals

About Amdocs Fundamental Analysis

Also Currently Popular

Additional Tools for Amdocs Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY